Lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: the German STAR/STELLA cohort

Trial Profile

Lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: the German STAR/STELLA cohort

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms STAR/STELLA
  • Most Recent Events

    • 16 Sep 2015 New trial record
    • 06 Nov 2014 Interim results in 1409 patients after 144 weeks' treatment presented at the 12th International Congress on Drug Therapy in HIV Infection.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top